Technology | 2010.01.13
Lifeline Biotechnologies Reports on FDA Filing Status
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today reported on the results of the FDA submission of its First Warning System™, filed in July 2009. Jim Holmes, Lifeline\'s CEO, said, "This past July we filed with the FDA to determine if our technology and testing of over 600 patients would meet the requirements for a 510(k). The FDA recently responded issuing a non-binding opinion as to the potential classification of the First Warning System™. The le
For more information, please visit
http://www.businesswire.com/news/home/20100113006245/en
